Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Biotechnology
Bio-Techne Corp (TECH) Q4 FY2024 Earnings: GAAP EPS of $0.25 Misses Estimates, Revenue of $306.1 Million Slightly Below Expectations
Bio-Techne Corp (TECH) released its 8-K filing on August 7, 2024, reporting mixed results for the fourth quarter of fiscal year 2024. Aug 07, 2024
GuruFocus Research Biotechnology
Rhythm Pharmaceuticals Inc (RYTM) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Key Regulatory Milestones
Rhythm Pharmaceuticals Inc (RYTM) reports a 12% revenue increase and significant progress in regulatory approvals and clinical trials. Aug 07, 2024